about
Tranexamic acid and trauma-induced coagulopathy.Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in JapanHead-to-head comparison of procalcitonin and presepsin for the diagnosis of sepsis in critically ill adult patients: a protocol for a systematic review and meta-analysis.Early rehabilitation for the prevention of postintensive care syndrome in critically ill patients: a study protocol for a systematic review and meta-analysis.Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials.Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock.Rapid and Sustained Long-Term Decrease of Fecal Short-Chain Fatty Acids in Critically Ill Patients With Systemic Inflammatory Response Syndrome.Clinical Significance of Tissue Factor and CD13 Double-Positive Microparticles in Sirs Patients with Trauma and Severe Sepsis.Effect of Histone Acetylation on N-Methyl-D-Aspartate 2B Receptor Subunits and Interleukin-1 Receptors in Association with Nociception-Related Somatosensory Cortex Dysfunction in a Mouse Model of Sepsis.Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trialNationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011-2013First clinical experiences of concurrent bleeding control and intracranial pressure monitoring using a hybrid emergency room system in patients with multiple injuriesGram stain-guided antibiotic choice: a GRACEful method to safely restrict overuse of broad-spectrum antibiotic agentsPrognostic accuracy of different disseminated intravascular coagulation criteria in critically ill adult patients: a protocol for a systematic review and meta-analysisVariations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in JapanImpact of initial coagulation and fibrinolytic markers on mortality in patients with severe blunt trauma: a multicentre retrospective observational studyExternal Validation of the Two Newly Proposed Criteria for Assessing Coagulopathy in SepsisEffect of the Hybrid Emergency Room System on Functional Outcome in Patients with Severe Traumatic Brain InjuryCharacteristics and outcomes of bacteremia among ICU-admitted patients with severe sepsisImpact of blood glucose abnormalities on outcomes and disease severity in patients with severe sepsis: An analysis from a multicenter, prospective survey of severe sepsisHistory of diabetes may delay antibiotic administration in patients with severe sepsis presenting to emergency departmentsTrends in sepsis care in Japan: comparison of two sepsis cohort studies conducted by the Japanese Association for Acute MedicineRecombinant Human Soluble Thrombomodulin in Sepsis-Induced Coagulopathy: An Updated Systematic Review and Meta-AnalysisA Systematic Summary of Systematic Reviews on Anticoagulant Therapy in SepsisNighttime and non-business days are not associated with increased risk of in-hospital mortality in patients with severe sepsis in intensive care units in Japan: The JAAM FORECAST studyImpact of Body Temperature Abnormalities on the Implementation of Sepsis Bundles and Outcomes in Patients With Severe Sepsis: A Retrospective Sub-Analysis of the Focused Outcome Research on Emergency Care for Acute Respiratory Distress Syndrome, SepClinical Significance of MicroRNAs in Patients with Sepsis: Protocol for a Systematic Review and Meta-AnalysisSignificance of plasma fibrinogen level and antithrombin activity in sepsis: A multicenter cohort study using a cubic spline modelProposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulationOptimal Timing and Early Intervention With Anticoagulant Therapy for Sepsis-Induced Disseminated Intravascular CoagulationInterventional radiology versus operative management for splenic injuries: a study protocol for a systematic review and meta-analysisIdentifying Sepsis Populations Benefitting from Anticoagulant Therapy: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression ModelPrognostic Accuracy of Quick SOFA is different according to the severity of illness in infectious patientsThe Treatment Intensity of Anticoagulant Therapy for Patients With Sepsis-Induced Disseminated Intravascular Coagulation and Outcomes: A Multicenter Cohort StudyPotential impacts of a novel integrated extracorporeal-CPR workflow using an interventional radiology and immediate whole-body computed tomography system in the emergency departmentRecombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysisEpidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systemsTrauma-induced coagulopathy: The past, present, and future: A comment
P50
Q33919354-C4688995-04C4-44F4-8979-94A8D0A77EA3Q37138741-00925210-0C6B-41EE-AC69-CD032D0E151DQ37704319-F4541FC9-B036-4422-B9B3-69084A4FC411Q37704349-1B98C0D7-441B-4B33-845D-14D11A6A4ECFQ38315541-75A690BE-40EE-4BF0-B76F-0756CD4AD283Q38670135-970F8A6D-F9AF-4C9C-A26A-7D5154E1CD4EQ38682155-D6DB6A35-57D8-4E26-9E19-D7C8F42AF0A8Q43744909-90119B24-CAE5-4991-99B8-F047C502AF18Q48770947-31958A10-6EAD-4E8C-B7C0-C100E203FD97Q49130246-9984CEEB-099B-41FD-BA2E-592937BE482FQ50699776-8679F9E9-D274-4501-8307-C9B4A8AB0EEAQ58590906-F7CEE719-17DC-4372-A5D7-B3CA65C0613CQ59789406-B7A84754-B81D-4AC4-8E5E-024E3C53DD87Q59802661-A3681ABA-C82E-4417-B2AB-75B8656B9BA8Q60044714-8D92A9ED-22B7-4AD3-A599-49AEEEAD9E9BQ60308243-628F8101-FA54-430D-A40E-9637AEA8A5D5Q64068676-8AEF506A-8302-49C3-8D0C-027833566CA1Q64092373-8C3F8D3A-A2C0-427F-BFB7-5E7F450608B0Q64119101-84CF5378-F7B9-4F9A-91CC-C48F69EC9953Q64123513-16C80A39-39D2-46BE-AF68-D26D8D6946ADQ89791268-DAA87C98-0D85-43EE-BCF5-50107047D771Q90236718-C24A88F4-54EE-4091-9D76-484933BB86B3Q90352747-5ABFA151-CEE6-4F45-BBD7-99DDCF3D71F1Q90582703-0FDC1B64-E8B2-4C52-BC1E-F5762047D1A1Q90827077-B81EB07A-0DA4-4C42-A11C-EF53AADCEF5DQ91126258-411C9DEA-A6AF-4D4B-9519-012706F5ECF8Q91609371-0F573894-F0E7-418B-8F75-C3F39FBCEAC1Q91790951-92492483-ECB3-4E99-AFB4-1F671BC73E62Q91807384-71DCF70D-1657-4311-86E4-D08282CDF535Q92043402-BDDE4AE1-8FFA-4AE5-9498-439CDAC37FF0Q92104310-6413788A-CB74-4D18-875B-5F8A09083780Q92174594-C761587A-186E-4103-BA4E-96ACBA97BCCEQ92547410-DCF2A83A-C6D7-493B-B30A-AE33957EB2B6Q92596172-442958B8-D586-423D-8667-BF41C452F7A9Q92640045-237A6EE2-7527-4CC2-824C-4196E2F7227FQ92666895-4CDA0AB7-8EB0-4836-9A38-527C889BFB2AQ92707420-0869359C-8540-430A-8563-ECDD9C12F8AAQ93129431-C320A7C8-252F-4551-9DFF-3B41B704774BQ93341013-DD765376-A73E-4B3A-B1D9-096D198926D2Q95573000-119CDA9B-E7C7-4A7D-A514-D6E452AFB989
P50
description
researcher
@en
name
Kazuma Yamakawa
@en
type
label
Kazuma Yamakawa
@en
prefLabel
Kazuma Yamakawa
@en
P31
P496
0000-0003-2999-4021